Repligen (NASDAQ: RGEN) Delivers Strong Q1 2026 Results and Positive Analyst Outlook
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameRepligen Corporation
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









